SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-011661
Filing Date
2019-06-27
Accepted
2019-06-27 17:00:52
Documents
1
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4469
  Complete submission text file 0001213900-19-011661.txt   6020
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 19926119